Effect of Diclofenac Sodium on macular edema

Effect of Diclofenac Sodium on CSME macular edema

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT201709217466N6

Enrollment

400

Registered

2017-11-19

Start date

2017-08-23

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic retinopathy. Diabetic retinopathy

Interventions

Intervention 1: Daily, for 3 months, Diclofenac. Intervention 2: Daily, for 3 months, Artificial tear drops.

Treatment - Drugs

Daily, for 3 months, Diclofenac

Daily, for 3 months, Artificial tear drops

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: inclusion criteria: Diabetic retinopathy and haVing informed consent Exclusion Criteria: CSME macular edema, Proliferative Diabetic retinopathy

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Macular Edema. Timepoint: Baseline, 3 Months later. Method of measurement: Test.	—

Secondary

Measure	Time frame
Retinopathy. Timepoint: Baseline, 3 months Later. Method of measurement: Test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Ali Arash Anoushirvani

Arak University of Medical Sciences

dr.anoushirvani@arakmu.ac.ir+98 86 3417 3645

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026